This section presents structured analysis on the impact of global healthcare funding reductions on primary healthcare systems and clinical trial supply chains. Drawing on field observations, operational frameworks, and historical public health patterns, the research focuses on how disruptions at the primary care level translate into measurable risks for clinical trial execution.

Healthcare Funding Impact
Assessment of recent global funding reductions and their effects on infectious disease programs, particularly HIV, tuberculosis, and malaria.

Primary Healthcare Infrastructure
Evaluation of PHCs as decentralized systems supporting both care delivery and clinical research, including infrastructure, staffing, and service capacity.

Clinical Trial Supply Chain Risk
Analysis of vulnerabilities in investigational product distribution, including cold chain management, inventory control, and site-level logistics.

Operational Frameworks
Structured models for PHC reestablishment, including infrastructure requirements, workforce training, and supply chain restoration.

Performance Metrics & Monitoring
Key indicators used to measure system reliability, including supply availability, temperature control, inventory accuracy, and resupply efficiency.

Sustainability & Long-Term Viability
Examination of funding continuity, governance, and operational consistency required to maintain both healthcare delivery and clinical trial readiness.